Structure activity relationships of 5-HT2B and 5-HT2C serotonin receptor antagonists: N6, C2 and 5′-Modified (N)-methanocarba-adenosine derivatives
Dilip K Tosh,Maggie M Calkins,Marko S Ivancich,Hailey A Bock,Ryan G Campbell,Sarah A Lewicki,Eric Chen,Zhan-Guo Gao,John D McCorvy,Kenneth A Jacobson,Dilip K. Tosh,Maggie M. Calkins,Marko S. Ivancich,Hailey A. Bock,Ryan G. Campbell,Sarah A. Lewicki,John D. McCorvy,Kenneth A. Jacobson
DOI: https://doi.org/10.1016/j.ejmech.2023.115691
IF: 7.088
2023-07-01
European Journal of Medicinal Chemistry
Abstract:(N)-Methanocarba adenosine derivatives were structurally modified to target 5-HT<sub>2B</sub> serotonin receptors as antagonists, predominantly containing branched N<sup>6</sup>-alkyl groups. N<sup>6</sup>-Dicycloalkyl-methyl groups, including their asymmetric variations, as well as 2-iodo, were found to generally favor 5-HT<sub>2</sub>Rs, while only N<sup>6</sup>-dicyclohexyl-methyl derivative 35 showed weak 5-HT<sub>2A</sub>R affinity (K<sub>i</sub> 3.6 μM). The highest 5-HT<sub>2B</sub>R affinities were K<sub>i</sub> 11-23 nM (N<sup>6</sup>-dicyclopropyl-methyl-2-iodo 11, 2-chloro-5'-deoxy-5'-methylthio 15 and N<sup>6</sup>-((R)-cyclobuty-cyclopropyl-methyl)-2-iodo 43), and K<sub>i</sub> 73 nM at 5-HT<sub>2C</sub>R for 36. Direct comparison of adenine ribosides and their corresponding rigid (N)-methanocarba derivatives (cf. 51 and MRS8099 45) indicated a multifold affinity enhancement with the bicyclic ring system. Compounds 43, 45 and 48 were functional 5-HT<sub>2B</sub>R (K<sub>B</sub> 2-3 nM) and 5-HT<sub>2C</sub>R (K<sub>B</sub> 79-328 nM) antagonists in a G<sub>q</sub>-mediated calcium flux assay, with 5-HT<sub>2B</sub>R functional selectivity ranging from 45- (48) to 113-fold (43). Substantial adenosine receptor (AR) affinity (K<sub>i</sub>, A<sub>1</sub>AR < K<sub>i</sub>, A<sub>3</sub>AR < K<sub>i</sub>, A<sub>2A</sub>AR) was still present in this series, suggestive of dual acting compounds: 5-HT<sub>2B</sub> antagonist and A<sub>1</sub>AR agonist, potentially useful for treating chronic conditions (fibrosis; pain). Given its affinity (17 nM) and moderate 5-HT<sub>2B</sub>R binding selectivity (32-fold vs. 5-HT<sub>2C</sub>R, 4-fold vs. A<sub>1</sub>AR), 43 (MRS7925) could potentially be useful for anti-fibrotic therapy.
chemistry, medicinal